rs62617809

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The ENST00000309585.9(DNASE1L1):​c.-351A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.83 ( 27229 hom., 27356 hem., cov: 23)
Exomes 𝑓: 0.77 ( 220394 hom. 281954 hem. )
Failed GnomAD Quality Control

Consequence

DNASE1L1
ENST00000309585.9 5_prime_UTR

Scores

1

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.267

Publications

8 publications found
Variant links:
Genes affected
DNASE1L1 (HGNC:2957): (deoxyribonuclease 1 like 1) This gene encodes a deoxyribonuclease protein that shows high sequence similarity to DNase I. The encoded protein is localized to the endoplasmic reticulum and modified by N-linked glycosylation. Alternate transcriptional splice variants encoding the same protein have been observed. [provided by RefSeq, Jan 2015]
TAFAZZIN (HGNC:11577): (tafazzin, phospholipid-lysophospholipid transacylase) This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq, Jul 2008]
TAFAZZIN Gene-Disease associations (from GenCC):
  • Barth syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAFAZZINNM_000116.5 linkc.110-17T>C intron_variant Intron 1 of 10 ENST00000601016.6 NP_000107.1 Q16635-1A0A0S2Z4K0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TAFAZZINENST00000601016.6 linkc.110-17T>C intron_variant Intron 1 of 10 1 NM_000116.5 ENSP00000469981.1 Q16635-1

Frequencies

GnomAD3 genomes
AF:
0.829
AC:
91819
AN:
110698
Hom.:
27230
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.965
Gnomad AMI
AF:
0.680
Gnomad AMR
AF:
0.874
Gnomad ASJ
AF:
0.667
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.963
Gnomad FIN
AF:
0.723
Gnomad MID
AF:
0.831
Gnomad NFE
AF:
0.746
Gnomad OTH
AF:
0.839
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.774
AC:
847641
AN:
1095538
Hom.:
220394
Cov.:
60
AF XY:
0.780
AC XY:
281954
AN XY:
361522
show subpopulations
African (AFR)
AF:
0.972
AC:
25657
AN:
26386
American (AMR)
AF:
0.915
AC:
32092
AN:
35062
Ashkenazi Jewish (ASJ)
AF:
0.676
AC:
13073
AN:
19339
East Asian (EAS)
AF:
1.00
AC:
30174
AN:
30185
South Asian (SAS)
AF:
0.955
AC:
51474
AN:
53904
European-Finnish (FIN)
AF:
0.725
AC:
28781
AN:
39697
Middle Eastern (MID)
AF:
0.874
AC:
3613
AN:
4135
European-Non Finnish (NFE)
AF:
0.745
AC:
626077
AN:
840854
Other (OTH)
AF:
0.798
AC:
36700
AN:
45976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
9019
18039
27058
36078
45097
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18512
37024
55536
74048
92560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.830
AC:
91865
AN:
110742
Hom.:
27229
Cov.:
23
AF XY:
0.830
AC XY:
27356
AN XY:
32964
show subpopulations
African (AFR)
AF:
0.965
AC:
29484
AN:
30543
American (AMR)
AF:
0.874
AC:
9278
AN:
10616
Ashkenazi Jewish (ASJ)
AF:
0.667
AC:
1754
AN:
2629
East Asian (EAS)
AF:
1.00
AC:
3455
AN:
3455
South Asian (SAS)
AF:
0.962
AC:
2506
AN:
2604
European-Finnish (FIN)
AF:
0.723
AC:
4276
AN:
5916
Middle Eastern (MID)
AF:
0.818
AC:
175
AN:
214
European-Non Finnish (NFE)
AF:
0.746
AC:
39214
AN:
52588
Other (OTH)
AF:
0.841
AC:
1268
AN:
1508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
546
1092
1639
2185
2731
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
754
1508
2262
3016
3770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.691
Hom.:
5698
Bravo
AF:
0.847

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
2.6
PhyloP100
-0.27
PromoterAI
-0.10
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62617809; hg19: chrX-153640406; API